RNR

Renaissancere Holdings Ltd

Add to Watchlist

Advanced Chart

241.870

+1.5(0.624%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

241.870

Open

240.400

VWAP

240.42

Vol

3.01K

Mkt Cap

11.31B

Low

240.400

Amount

723.67K

EV/EBITDA(TTM)

6.96

Total Shares

52.88M

19.94B

EV/OCF(TTM)

5.12

P/S(TTM)

0.95

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance, focused on aligning risk with capital. It offers property, casualty, and specialty reinsurance, along with certain insurance solutions, primarily through intermediaries. It has two reportable segments: Property and Casualty and Specialty. The Property segment includes catastrophe reinsurance, primarily excess of loss and retrocessional coverage for natural and man-made disasters, as well as other property business such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional multi-line business. The Casualty and Specialty segment encompasses reinsurance activities across a range of complex, longer-tail risk categories, including general casualty, professional liability, credit, and other specialty lines of reinsurance. The Company combines data, technology, and the ability to deliver risk solutions and capacity through owned and managed partner balance sheets.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

3.24B

-5.93%

9.995

-770.78%

1.71B

-2.53%

7.730

-4.09%

2.04B

-5.52%

4.926

-51.85%

Estimates Revision

The market is revising Downward the revenue expectations for RenaissanceRe Holdings Ltd. (RNR) for FY2025, with the revenue forecasts being adjusted by -1.31% over the past three months. During the same period, the stock price has changed by -2.56%.

Revenue Estimates for FY2025

Revise Downward

-1.31%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+13.35%

In Past 3 Month

Stock Price

Go Down

-2.56%

In Past 3 Month

10 Analyst Rating

11.95% Upside

Wall Street analysts forecast RNR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RNR is 270.78 USD with a low forecast of 237.00 USD and a high forecast of 303.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

5 Hold

1 Sell

Moderate Buy

11.95% Upside

Current: 241.870

Low

237.00

Averages

270.78

High

303.00

11.95% Upside

Current: 241.870

Low

237.00

Averages

270.78

High

303.00

Keefe Bruyette

Market Perform

maintain

$268 -> $269

2025-07-28

Reason

Keefe Bruyette

Price Target

$268 -> $269

2025-07-28

maintain

Market Perform

Reason

Keefe Bruyette raised the firm's price target on RenaissanceRe to $269 from $268 and keeps a Market Perform rating on the shares.

UBS

Neutral

maintain

$250 -> $265

2025-07-28

Reason

UBS

Price Target

$250 -> $265

2025-07-28

maintain

Neutral

Reason

UBS raised the firm's price target on RenaissanceRe to $265 from $250 and keeps a Neutral rating on the shares.

Barclays

Equal Weight

maintain

$256 -> $273

2025-07-24

Reason

Barclays

Price Target

$256 -> $273

2025-07-24

maintain

Equal Weight

Reason

Barclays raised the firm's price target on RenaissanceRe to $273 from $256 and keeps an Equal Weight rating on the shares. The company reported a Q2 earnings beat on strong prior year development and higher underlying margins, the analyst tells investors in a research note.

Morgan Stanley

Overweight

downgrade

$285 -> $280

2025-07-14

Reason

Morgan Stanley

Price Target

$285 -> $280

2025-07-14

downgrade

Overweight

Reason

Morgan Stanley lowered the firm's price target on RenaissanceRe to $280 from $285 and keeps an Overweight rating on the shares.

Wells Fargo

Elyse Greenspan

Overweight -> Equal Weight

downgrade

$267 -> $269

2025-07-10

Reason

Wells Fargo

Elyse Greenspan

Price Target

$267 -> $269

2025-07-10

downgrade

Overweight -> Equal Weight

Reason

Wells Fargo analyst Elyse Greenspan downgraded RenaissanceRe to Equal Weight from Overweight with a price target of $269, up from $267. The firm cites a slowing property catastrophe reinsurance market for the downgrade. The company's Q2 "could be good" but then it is enters peak of storm season, the analyst tells investors in a research note. Wells adds that property catastrophe rates declined in the double-digit range during the mid-year renewals.

Keefe Bruyette

Meyer Shields

Outperform -> Market Perform

downgrade

$282 -> $268

2025-07-08

Reason

Keefe Bruyette

Meyer Shields

Price Target

$282 -> $268

2025-07-08

downgrade

Outperform -> Market Perform

Reason

Keefe Bruyette analyst Meyer Shields downgraded RenaissanceRe to Market Perform from Outperform with a price target of $268, down from $282. The firm adjusted ratings on the property and casualty space as part of Q2 preview. It believes catastrophe losses in the quarter suggest that pricing, loss trends, reserve development and capital deployment will dominate the earnings calls. Keefe expects moderate catastrophe losses but mostly reduced price targets to reflect tariff-related uncerintaty. It upgraded The Hanover and downgraded both Arch Capital and RenaissanceRe Holdings.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Renaissancere Holdings Ltd (RNR.N) is 7.28, compared to its 5-year average forward P/E of 13.64. For a more detailed relative valuation and DCF analysis to assess Renaissancere Holdings Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

13.64

Current PE

7.28

Overvalued PE

39.31

Undervalued PE

-12.04

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.20

Current PS

1.15

Overvalued PS

1.43

Undervalued PS

0.96